Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-05

Clinical Trial Update: Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis Failing Adalimumab

View source ↗

Summary

A completed clinical trial evaluating golimumab for juvenile idiopathic arthritis-associated uveitis that is failing adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Golimumab (golimumab)

Snippet

Sponsor: Medical University of Graz | Conditions: JIA Associated Uveitis | Status: COMPLETED | Results posted: 2022-05-05